Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 3.3B | 3.0B | 2.1B | 2.3B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | 40M |
| Other operating expenses | 429M | 417M | 316M | 217M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 2.2B | 1.7B | 1.7B | 1.5B |
| Tax provision | 449M | 350M | 254M | 311M |
| Net income | 1.7B | 1.4B | 1.5B | 1.2B |
| Basic EPS | 4.4 | 3.5 | 5.2 | 4.2 |
| Diluted EPS | 4.4 | 3.5 | 5.2 | 4.2 |
| Basic average shares | 375.5M | 375.6M | 264.2M | 264.0M |
| Diluted average shares | 375.5M | 375.6M | 264.2M | 264.0M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | 0 | -1M | — | — |
| Preferred stock dividends | 96M | 82M | 79M | 53M |